Okla. Needs $295M To Undo J&J Opioid Marketing, Judge Told
Law360 (June 10, 2019, 10:44 PM EDT) -- Oklahoma will need to spend almost $295 million over 20 years to counteract Johnson & Johnson's opioid marketing efforts, a marketing executive testified for the state on Monday during its first-in-the-nation trial over corporate responsibility for the opioid crisis.
At the start of the third week of the bench trial in Norman, Oklahoma, the state called to the stand C. Renzi Stone, CEO of marketing firm Saxum, to give an expert take on the marketing done by J&J and its subsidiary Janssen Pharmaceuticals.
Under questioning by Reggie Whitten of Whitten Burrage, who represents the state, Stone said that after reviewing roughly 1,200...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!